[1] | ADA. Standarts of medical care in diabetes-2019. Diabetes Care. 2019; 24(1): s1-s187. |
[2] | Akhter N, Madhoun A, Arefanian H, et al. Oxidative stress induces expression of the Toll-Like Receptors (TLRs) 2 and 4 in the human peripheral blood mononuclear cells: implications for metabolic inflammation. Cell. Physiol. Biochem. 2019; 53(1): 1-18. doi: . |
[3] | American Society for Metabolic & Bariatric Surgery Updates to the 2014-2015) |
[4] | Bray GA, Frühbeck G, Ryan DH, Wilding JPH. Management of obesity. Lancet. 2016; 387(10031): 1947-1956. doi: |
[5] | Aminian A. The choice of bariatric procedure in patients with diabetes type 2 diabetes: a choice between gastric bypass by the Ru-an-I method or sleeve resection of the stomach. Surgery related to Dis. 2020; 16(2): 332-339 dpi: https://doi.org/10.1016/j.soard.2019.11.013. |
[6] | Buchwald H., Avidor U., Braunwald E. et al. Bariatric surgery: systematic review and meta-analysis. JAMA. 2004; 292(14): 1724-1737. dpi: https://doi.org/10.1001/jama.292.14.1724. |
[7] | Buchwald H., Estok R., Farbach K. et al. Mortality trends in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007; 142(4): 621-635. doi: https://doi.org/10.1016/j.surg.2007.07.018. |
[8] | Buchwald H., Estok R., Farbach K. et al. Weight and type of type 2 diabetes after bariatric surgery: a systematic review and meta-analysis. I'm Jay Honey. 2009; 122(3): 248-256. e5. dpi: https://doi.org/10.1016/j.amjmed.2008.09.041. |
[9] | Buchwald H, Varco R. Metabolic surgery. New York: Grune & Stratton; 1978. Char. 11. |
[10] | Cheng L, Wang J, Dai H, et al. Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus. Adipocyte. 2021; 10(1): 48-65. https://doi.org/10.1080/21623945.2020.1870060. |
[11] | Cheng L, Yan W, Zhu L, et al. Comparative analysis of IDF, ATPIII and CDS in the diagnosis of metabolic syndrome among adult inhabitants in Jiangxi Province, China. PLoS One. 2017; 12(12): e0189046. doi: https://doi.org/10.1371/journal.pone.0189046. |
[12] | Dedov I.I., Mokrysheva N.G., Melnichenko G.A., etc. Fatness. Clinical recommendations. M.: Russian Association of Endocrinologists; 2020. 43 p. [Dedov II, Mokrysheva NG, Melnichenko GA, et al. Obesity. Clinical recommendations. Moscow: Russian Association of Endocrinologists; 2020. 43 p. (In Russ.)] |
[13] | Dedov I.I., Shestakova M.V., Melnichenko G.A., etc. Interdisciplinary clinical recommendations "Treatment of obesity and comorbid diseases" // Obesity and metabolism. 2021. Vol. 18. No1. pp. 5-99. [Dedov II, Shestakova MV, Melnichenko GA, et al. Interdisciplinary clinical practice guidelines «Management of obesity and its comorbidities» Obesity and metabolism. 2021; 18(1): 5-99. (In Russ.)]. doi: . |
[14] | Dedov I.I., Shestakova M.V., Melnichenko G.A., etc. Interdisciplinary clinical guidelines "Treatment of obesity and comorbid diseases" // Obesity and metabolism. 2021. Vol. 18. No1. pp. 5-99. [Dedov II, Shestakova MV, Melnichenko GA, et al. Interdisciplinary clinical practice guidelines «Management of obesity and its comorbidities». Obesity and metabolism. 2021; 18(1): 5-99. (In Russ.)]. doi: https://doi.org/10.14341/omet12714. |
[15] | Dedov I.I., Tkachuk V.A., Gusev N.B., et al. Type 2 diabetes mellitus and metabolic syndrome: molecular mechanisms, key signaling pathways and determination of biomishens for new drugs // Diabetes mellitus. - 2018. Vol. 21. No5. pp. 364-375. [Dedov II, Tkachuk VA, Gusev NB, et al. Type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets. Diabetes mellitus. 2018; 21(5): 364-375. (In Russ.)]. doi: https://doi.org/10.14341/DM9730. |
[16] | Di Domenico M, Pinto F, Quagliuolo L, et al. The Role of Oxidative Stress and Hormones in Controlling Obesity. Front Endocrinol (Lausanne). 2019; 10(3): 58-65. doi: https://doi.org/10.3389/fendo.2019.00540. |
[17] | Dyer AR, Elliott P, Shipley M. Body mass index versus height and weight in relation to blood pressure. Findings for the 10,079 persons in the INTERSALT Study. Am J Epidemiol. 1990; 131(4): 589-596. doi: . |
[18] | El Bizri I, Batsis JA. Linking epidemiology and molecular mechanisms in sarcopenic obesity in populations. Proc Nutr Soc. 2020; 79(4): 448-456. doi: . |
[19] | Ershova E.V. Glucose, lipid metabolism and incretin production in patients with obesity and type 2 diabetes mellitus after biliopancreatic bypass surgery: Dis. ... cand. med. Sciences. M.; 2016. [Yershova E.V. Exchange of glucose, lipids and incretin production in patients with obesity and type 2 diabetes mellitus after biliopancreatic bypass surgery [Dissertation]. Moscow; 2016. (In Russian)]. |
[20] | Fried M, Yumuk V, Oppert J et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. International Federation for the Surgery of Obesity and Metabolic Disorders – European Chapter (IFSO – EC) and European Association for the Study of Obesity (EASO). Obes Surg 2014; 24 (1): 42–55. |
[21] | Garvey WT, Mechanick JI, Brett EM, et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. EndocrPract. 2016; 22(3): 1-203. doi: https://doi.org/10.4158/EP161365. |
[22] | Gesta S., Tseng Y.H., Kan C.R. The evolutionary origin of fat: tracking obesity to its source. Cell. (2007) 131: 242–56. doi: 10.1016/j.cell.2007.10.004. |
[23] | Hartz AJ, Rupley DC Jr, Kalkhoff RD, Rimm AA. Relationship of obesity to diabetes: influence of obesity level and body fat distribution. Prev Med. (1983) 12:351–7. doi: 10.1016/0091-7435(83)90244-X18. |
[24] | Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol 2011; 108: 1499-507. |
[25] | Horgami Z., Shoar S., Saber A.A., etc. Results of bariatric surgery in comparison with drug treatment of type 2 diabetes mellitus: meta-analysis of randomized controlled trials. WTO Surgery. 2019; 29(3): 964-974. dpi: . |
[26] | Ikramuddin S., Korner J., Lee W.-J. et al. Gastric bypass by the Ru-an-I method in comparison with intensive medical treatment for the control of type 2 diabetes, hypertension and hyperlipidemia. JAMA. 2013; 309(21): 2240-2249. dpi: https://doi.org/10.1001/jama.2013.5835. |
[27] | Ikramuddin S., Korner J., Lee W.-J. et al. Lifestyle changes and drug treatment with vs without gastric bypass by the Ru-an-I method and control of hemoglobin A1c, LDL cholesterol and systolic blood pressure for 5 years in the study "Diabetes Surgery". JAMA. 2018; 319(3): 266-278. |
[28] | Jih J, Mukherjea A, Vittinghoff E, et al. Using appropriate body mass index cut points for overweight and obesity among Asian Americans. Prev Med (Baltim). 2014; 65: 1-6. doi: |
[29] | Kremen AJ, Linner JH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954; 140(3): 439. doi: https://doi.org/10.1097/00000658-195409000-00018. |
[30] | Laferrer B, Heshka C, Van K, etc. Incretin levels and the effect increase markedly 1 month after gastric bypass surgery using the Ru-an-i method in patients with obesity and type 2 diabetes mellitus. Diabetes treatment. 2007; 30(7): 1709-1716. doi: https://doi.org/10.2337/dc06-1549. |
[31] | Ludwig DS, Ebbeling CB. Weight-Loss Maintenance Mind over Matter? N Engl J Med. 2010; 363(22): 2159-2161. doi: https://doi.org/10.1056/NEJMe1011361. |
[32] | Mason E., Ito S. Gastric bypass surgery in obesity. Surgical clinics north of Am. 1967; 47(6): 1345-1351. doi: https://doi.org/10.1016/s0039-6109 (16)38384-0. |
[33] | McKee AM, Morley JE. Obesity in the Elderly. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2021. |
[34] | McKee AM, Morley JE. Obesity in the Elderly. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText. com, Inc.; 2021. |
[35] | Mingrone G., Panunzi S., De Gaetano A. et al. Bariatric surgery versus traditional drug therapy for type 2 diabetes. In English J Med. 2012; 366(17): 1577-1585 doi: https://doi.org/10.1056/NEJMoa1200111. |
[36] | Misra A, Jayawardena R, Anoop S. Obesity in South Asia: Phenotype, Morbidities, and Mitigation. Curr Obes Rep. 2019; 8(1): 43-52. doi: https://doi.org/10.1007/s13679-019-0328-0. |
[37] | Nam GE, Park HS. Perspective on Diagnostic Criteria for Obesity and Abdominal Obesity in Korean Adults. J Obes Metab Syndr. 2018; 27(3): 134-142. doi: https://doi.org/10.7570/jomes.2018.27.3.134. |
[38] | Ng M, Fleming T, Robinson M, et al. Summary of Revisions: Standards of Medical Care in Diabetes 2022. Diabetes Care. 2022; 45(S1): S4-S7. doi: . |
[39] | Nishida C, Barba C, Cavalli-Sforza T, et al. Appropriate bodymass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403): 157-163. doi: https://doi.org/10.1016/S0140-6736(03)15268-3. |
[40] | Obesity and overweight. WHO. (as of March 10, 2019). |
[41] | Osadchuk A.M., Loranskaya I.D., Osadchuk M.A. Obesity and cancer. Two sides of the same problem // Preventive medicine. 2021. Vol. 24. No8. pp. 95-100. [Osadchuk AM, Loranskaya ID, Osadchuk MA. Obesity and cancer. Two sides of the same problem. Profil meditsina. 2021; 24(8): 95-100. (In Russ.)]. doi: . |
[42] | Pan W-H, Yeh W-T. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr. 2008. doi: . |
[43] | Payne JH, DeWind LT, Commons RR. Metabolic observations in patients with jejunocolic shunts. Am J Surg. 1963; 106(2): 273-289. dpi: https://doi.org/10.1016/0002-9610 (63)90017-5. |
[44] | Pori U.J., McDonald K.G., Flickinger E.G., etc. Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surgut, 1992; 215(6): 633-643. https://doi.org/10.1097/00000658-199206000-00010. |
[45] | Pori U.J., Swanson M.S., McDonald K.G., etc. Who would have thought? the operation turns out to be the most effective method of treatment diabetes mellitus in adults. Ann Surgut, 1995; 222(3): 339-352. https://doi.org/10.1097/00000658-199509000-0001. |
[46] | Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willett WC. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. (1995). |
[47] | Sakurai Y, Kubota N, Toshimasa Y, Kadowaki T. Role of insulin resistance in MAFLD. Int J Mol Sci. 2021; 22 (8): 4156-4182. doi: . |
[48] | Saltiel AR. Insulin signaling in health and disease. J Clin Invest. 2021; 131(1): e142241. doi: https://doi.org/https://doi.org/10.1172/JCI142241. |
[49] | Schauer PR, Bhatt D.L., Kirwan J.P. et al. Bariatric surgery in comparison with intensive drug therapy for diabetes results for 5 years. In English J Med. 2017; 376(7): 641-651 doi: https://doi.org/10.1056/NEJMoa1600869. |
[50] | Wu H, Ballantyne ChM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020; 126 (11): 1549–1564. doi: https://doi.org/10.1161/CIRCRESAHA.119.315896]. |
[51] | Zeng Q, He Y, Dong S, et al. Optimal cut-off values of BMI, waist circumference and waist: height ratio for defining obesity in Chinese adults. Br J Nutr. 2014; 112(10): 1735-1744. doi: https://doi.org/10.1017/S0007114514002657. |